FocalTherics reports Q2 2026 HIFU revenue up to 39% year-over-year
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/23/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
FocalTherics™ Reports Preliminary Financial Results for Second Quarter of 2026
August 11, 2026 4:28 PM EDTFocalTherics Reports Preliminary Financial Results for Second Quarter of 2026
AUSTIN, Texas, Aug. 11, 2026 (GLOBE NEWSWIRE) -- FocalTherics (Nasdaq: FOCL) (the Company), a global leader in robotic focal therapy, today announced preliminary unaudited financial results for the Companys HIFU segment, reported as continuing operations, for the second quarter of 2026.Â
During the second quarter of 2026, the Extracorporeal Shock Wave Lithotripsy (ESWL) and Distribution segments met the criteria to be classified as held for sale under ASC 205-20, Presentation of Financial Statements Discontinued Operations, and ASC 360-10, Property, Plant, and Equipment, and the... More
